Human Infections with Non-O157 Shiga Toxin–producing Escherichia coli, Switzerland, 2000–2009

We characterized 97 non-O157 Shiga toxin (stx)–producing Escherichia coli strains isolated from human patients during 2000–2009 from the national reference laboratory in Switzerland. These strains belonged to 40 O:H serotypes; 4 serotypes (O26:H11/H–, O103:H2, O121:H19, and O145:H28/H–) accounted for 46.4% of the strains. Nonbloody diarrhea was reported by 23.2% of the patients, bloody diarrhea by 56.8%. Hemolytic uremic syndrome developed in 40.0% of patients; serotype O26:H11/H– was most often associated with this syndrome. Forty-five (46.4%) strains carried stx2 genes only, 36 strains (37.1%) carried stx1, and 16 (16.5%) strains carried stx1 and stx2. Genes encoding enterohemolysin and intimin were detected in 75.3% and 70.1% of the strains, respectively. Resistance to >1 antimicrobial agent was present in 25 isolates. High genetic diversity within strains indicates that non-O157 stx–producing E. coli infections in Switzerland most often occurred as single cases.

[1]  Efsa Journal,et al.  European Food Safety Authority, European Centre for Disease Prevention and Control; The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2009 , 2011 .

[2]  Efsa Publication,et al.  The Community Summary Report on Trends and Sources of Zoonoses in 2008 , 2010 .

[3]  J. Besser,et al.  Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  A. Mellmann,et al.  Shiga Toxin, Cytolethal Distending Toxin, and Hemolysin Repertoires in Clinical Escherichia coli O91 Isolates , 2009, Journal of Clinical Microbiology.

[5]  L. Beutin,et al.  Shiga Toxin–producing Escherichia coli Serogroups in Food and Patients, Germany , 2008, Emerging infectious diseases.

[6]  H. Karch,et al.  Activatable Shiga toxin 2d (Stx2d) in STEC strains isolated from cattle and sheep at slaughter. , 2008, Veterinary microbiology.

[7]  A. Mellmann,et al.  Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.

[8]  N. Pradel,et al.  Molecular Analysis of Shiga Toxin-Producing Escherichia coli Strains Isolated from Hemolytic-Uremic Syndrome Patients and Dairy Samples in France , 2008, Applied and Environmental Microbiology.

[9]  Clinical,et al.  Performance standards for antimicrobial disk and dilution susceptibilty tests for bacteria isolated from animals : approved standard , 2008 .

[10]  L. Beutin,et al.  Identification of Human-Pathogenic Strains of Shiga Toxin-Producing Escherichia coli from Food by a Combination of Serotyping and Molecular Typing of Shiga Toxin Genes , 2007, Applied and Environmental Microbiology.

[11]  K. Bettelheim.  The Non-O157 Shiga-Toxigenic (Verocytotoxigenic) Escherichia coli; Under-Rated Pathogens , 2007, Critical reviews in microbiology.

[12]  C. Sears,et al.  The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Wells,et al.  Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. , 2005, The Journal of infectious diseases.

[14]  H. Karch,et al.  Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.

[15]  J. Blanco,et al.  Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain. , 2005, Research in microbiology.

[16]  H. Karch,et al.  Molecular Profiling and Phenotype Analysis of Escherichia coli O26:H11 and O26:NM: Secular and Geographic Consistency of Enterohemorrhagic and Enteropathogenic Isolates , 2005, Journal of Clinical Microbiology.

[17]  P. Gerner-Smidt,et al.  VTEC O117:K1:H7 A new clonal group of E. coli associated with persistent diarrhoea in Danish travellers , 2005, Scandinavian journal of infectious diseases.

[18]  J. Blanco,et al.  Serotypes and virulence genes of ovine non-O157 Shiga toxin-producing Escherichia coli in Switzerland. , 2004, International journal of food microbiology.

[19]  L. Beutin,et al.  Characterization of Shiga Toxin-Producing Escherichia coli Strains Isolated from Human Patients in Germany over a 3-Year Period , 2004, Journal of Clinical Microbiology.

[20]  J. Blanco,et al.  Serotypes, Virulence Genes, and Intimin Types of Shiga Toxin (Verotoxin)-Producing Escherichia coli Isolates from Human Patients: Prevalence in Lugo, Spain, from 1992 through 1999 , 2004, Journal of Clinical Microbiology.

[21]  J. Heesemann,et al.  Differentiation in virulence patterns of Escherichia coli possessing eae genes , 1994, Medical Microbiology and Immunology.

[22]  J. Kaper,et al.  Association of Genomic O Island 122 of Escherichia coli EDL 933 with Verocytotoxin-Producing Escherichia coli Seropathotypes That Are Linked to Epidemic and/or Serious Disease , 2003, Journal of Clinical Microbiology.

[23]  P. McDermott,et al.  Antimicrobial Resistance of Escherichia coli O26, O103, O111, O128, and O145 from Animals and Humans , 2002, Emerging infectious diseases.

[24]  D. Tompkins,et al.  Vero cytotoxin-producing Escherichia coli in a study of infectious intestinal disease in England. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  A. Siitonen,et al.  Clinical Isolates of Non-O157 Shiga Toxin-ProducingEscherichia coli: Serotypes, Virulence Characteristics, and Molecular Profiles of Strains of the Same Serotype , 2001, Journal of Clinical Microbiology.

[26]  S. McEwen,et al.  Associations between Virulence Factors of Shiga Toxin-ProducingEscherichia coli and Disease in Humans , 1999, Journal of Clinical Microbiology.

[27]  H. Karch,et al.  Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. , 1999, The Journal of infectious diseases.

[28]  S. Lauwers,et al.  Identification of New Verocytotoxin Type 2 Variant B-Subunit Genes in Human and Animal Escherichia coliIsolates , 1998, Journal of Clinical Microbiology.

[29]  James C. Paton,et al.  Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections , 1998, Clinical Microbiology Reviews.

[30]  J Ruiz,et al.  Isolation of verotoxin-producing Escherichia coli O-rough:K1:H7 from two patients with traveler's diarrhea , 1997, Journal of clinical microbiology.

[31]  A. Caprioli,et al.  Genotyping of Shiga-like toxin genes in non-O157 Escherichia coli strains associated with haemolytic uraemic syndrome. , 1995, Journal of medical microbiology.

[32]  L. Beutin,et al.  Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933 , 1995, Infection and immunity.